secwatch.observer — SEC 8-K summary
======================================

Issuer:     RANGE IMPACT, INC. (RNGE)
CIK:        0001438943
Form:       8-K
Filed at:   2021-08-12T23:59:59+00:00
Accession:  0001493152-21-019541
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vitality Biopharma shareholders elect directors and approve 2021 Stock Incentive Plan at annual meeting.
--------------------------------------------------------------------------------

- Edward Feighan, Richard Celeste, Michael Cavanaugh elected as directors with >98% votes for.
- 2021 Stock Incentive Plan approved: 21,209,644 votes for, 638,306 against.
- Advisory vote on executive compensation approved: 21,298,713 for, 523,948 against.
- Stockholders preferred advisory votes on exec comp every 3 years (21,021,589 votes); board adopted that frequency.
- Ratification of Meaden & Moore as auditor: 27,454,815 for, 101,379 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438943/000149315221019541/0001493152-21-019541-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438943/000149315221019541/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-019541

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer